We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.8B
AUM Growth
+$1.27B
(+3.7%)
Cap. Flow
-$817M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,236
Closed
310
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$563M |
| 2 |
McDonald's
MCD
|
+$357M |
| 3 |
Tesla
TSLA
|
+$268M |
| 4 |
Advanced Micro Devices
AMD
|
+$253M |
| 5 |
PayPal
PYPL
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$485M |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Merck
MRK
|
+$217M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Healthcare | 17.85% |
| 3 | Industrials | 11.58% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2301
DELISTED
Invacare Corporation
IVC
| $98.5K | ﹤0.01% |
234,456
-285,489
| -55% | -$153K |
|
|
KNDI
2302
Kandi Technologies Group
KNDI
$63.5M
| $97.5K | ﹤0.01% |
42,400
-62,100
| -59% | -$163K |
|
|
GBIO
2303
DELISTED
Generation Bio
GBIO
| $97.5K | ﹤0.01% |
2,480
-1,240
| -33% | -$65.1K |
|
|
HIMX
2304
Himax Technologies
HIMX
$2.09B
| $96.9K | ﹤0.01% |
15,600
-21,600
| -58% | -$137K |
|
2305
Voyager Therapeutics
VYGR
$184M
| $94.5K | ﹤0.01% |
15,500
-16,800
| -52% | -$95.5K |
|
|
AMTI
2306
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $94K | ﹤0.01% |
223,800
-106,100
| -32% | -$107K |
|
|
FSP
2307
Franklin Street Properties
FSP
$50.1M
| $92.3K | ﹤0.01% |
33,800
-3,400
| -9% | -$9.41K |
|
2308
Lufax Holding
LU
$1.33B
| $91K | ﹤0.01% |
+11,725
| New | +$89.3K |
|
2309
Verrica Pharmaceuticals
VRCA
$92.8M
| $90.5K | ﹤0.01% |
3,290
+2,030
| +161% | +$54.2K |
|
2310
RPC Inc
RES
$1.14B
| $90.2K | ﹤0.01% |
+10,142
| New | +$91.6K |
|
|
LYRA
2311
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $89.8K | ﹤0.01% |
572
-284
| -33% | -$56.2K |
|
|
VNTR
2312
DELISTED
Venator Materials PLC
VNTR
| $86.3K | ﹤0.01% |
159,900
-116,300
| -42% | -$81.1K |
|
|
TAST
2313
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $84.1K | ﹤0.01% |
61,861
-13,300
| -18% | -$20.7K |
|
|
TESS
2314
DELISTED
Tessco Technologies Inc
TESS
| $83.8K | ﹤0.01% |
17,100
-4,600
| -21% | -$21.4K |
|
2315
Imunon
IMNN
$6.43M
| $83.3K | ﹤0.01% |
4,732
-2,322
| -33% | -$44.7K |
|
2316
CVD Equipment Corp
CVV
$46.7M
| $83.2K | ﹤0.01% |
15,100
-100
| -0.7% | -$558 |
|
|
NAGE
2317
Niagen Bioscience
NAGE
$262M
| $82.7K | ﹤0.01% |
49,200
+7,200
| +17% | +$11.4K |
|
|
OTLY
2318
Oatly Group
OTLY
$473M
| $82.1K | ﹤0.01% |
2,360
-10,270
| -81% | -$392K |
|
|
LNAI
2319
Lunai Bioworks
LNAI
$10.2M
| $80.4K | ﹤0.01% |
976
-414
| -30% | -$55.6K |
|
2320
Vivid Seats
SEAT
$88.7M
| $79.6K | ﹤0.01% |
545
-315
| -37% | -$48.9K |
|
2321
Joby Aviation
JOBY
$7.15B
| $79.4K | ﹤0.01% |
+23,700
| New | +$96K |
|
|
TCON
2322
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $79.3K | ﹤0.01% |
2,660
-2,375
| -47% | -$71.8K |
|
2323
Aligos Therapeutics
ALGS
$26.3M
| $78.6K | ﹤0.01% |
3,300
-1,400
| -30% | -$35.3K |
|
2324
Vroom Inc
VRM
$36.8M
| $77.9K | ﹤0.01% |
+955
| New | +$82K |
|
2325
Custom Truck One Source
CTOS
$2.35B
| $77.1K | ﹤0.01% |
12,200
-7,700
| -39% | -$49.9K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Two Sigma Advisers held 2,806 positions worth $35.8B, up 3.7% from $34.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q4 2022 filing shows 288 new, 941 increased, 1,236 reduced and 310 closed positions. Its largest new stake was Advanced Micro Devices: 3,833,640 shares worth $248M. The largest sale was JPMorgan Chase, an estimated $485M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q4 2022 buy was Advanced Micro Devices: 3,833,640 shares worth $248M.
- Two Sigma Advisers added most to Amazon in Q4 2022, an estimated $563M increase.
- Two Sigma Advisers's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $485M.
- Two Sigma Advisers fully exited NVIDIA in Q4 2022, selling an estimated $140M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $35.8B portfolio in Q4 2022.
- Two Sigma Advisers opened 288 new positions and closed 310 in Q4 2022.
- Two Sigma Advisers's portfolio value rose 3.7% quarter-over-quarter to $35.8B.
Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.